Continuing Medical Education Series

Advances and Updates in Urologic Oncology

Register for the Series

Join us for our virtual didactic lecture series on critical topics and innovations in genitourinary oncology.

Earn one AMA PRA Category 1 Credit(s)™ is available per session.

Led by Ashley E. Ross, MD, PhD, the conference takes place the third Thursday of the month following GU Oncology Conference at 5:30 pm CST. Dr. Ross is a surgeon-scientist at Northwestern University Feinberg School of Medicine and member of Robert H. Lurie Comprehensive Cancer Center at Northwestern University who specializes in urology and urologic oncology, and is a nationally recognized expert in prostate cancer. 

Find Upcoming Events In Our Series

Video Archive

Hypofractionated Radiation Treatment for Treatment of Prostate Cancer

Northwestern Medicine Radiation Oncologists, William Hartsell, MD, Nasir Mohammed, MD, MBA, Stephen Mihalcik, MD, PhD, and Adil Akthar, MD, discuss fractionation of radiation therapy treatment in prostate cancer.

Management of Recurring Prostate Cancer: Can Radiation Help?

Sean Sachdev, Assistant Professor of Radiation Oncology at the Feinberg School of Medicine at Northwestern University, discusses the use of radiation for the management of recurring prostate cancer.

PI3K/Akt Pathway Inhibition for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

David VanderWeele, MD, PhD, Assistant Professor of Medicine (Hematology and Oncology) at Northwestern University Feinberg School of Medicine, discusses the PI3K/AKT pathway and its role in cancer, PI3K/AKT pathway alterations in prostate cancer, and inhibitors of the pathway and recent clinical trial results.

Small Molecule MYC Inhibitors for Cancer Therapy

Sarki Abdulkadir, MD, PhD, discusses his research on the MYC protein and its role in cancer treatment.

Updates on Management of Metastatic Hormone-Sensitive Prostate Cancer

Alicia Morgans, MD, MPH, discusses management options for patients with metastatic hormone-sensitive prostate cancer.

Bladder Cancer: Best of Journals

Shilajit Kundu, MD and Joshua Meeks, MD, PhD, discuss practice changing articles in bladder cancer.

Non-Radical Treatments for Prostate Cancer

Ashley Ross, MD, PhD, reviews sub-total glad therapies for prostate cancer, including patient selection and considerations, treatment selection and outcomes.

Management of Testis Cancer

Presented by the Polsky Urologic Cancer Institute at Northwestern Medicine, "Advances and Updates in Urologic Oncology" is a virtual didactic lecture series on critical topics and innovations in genitourinary oncology. In this video, Sia Daneshmand, MD, Professor of Urology and Director of Clinical Research at the University of Southern California, discusses the current management of testis cancer.

Enhancing Minority Recruitment and Participation in Clinical Trials

Adam Murphy, MD, MBS, MSCI, Assistant Professor of Urology, reviews factors that may influence minority recruitment and participation in clinical trials and presents strategies for increasing diversity in clinical trials.

Highlights in Urologic Oncology from ASCO 2021

David VanderWeele, MD, PhD, Assistant Professor of Medicine in Hematology/Oncology, reviews the clinical and translational GU oncology research presented during the 2021 ASCO annual meeting.

Prostate Biopsy Techniques: Ways to Optimize Cancer Detection and Ensure Patient Safety

Drs. Edward Schaeffer and Matthew Allaway discuss tools for optimizing prostate biopsy to enhance detection of clinically significant cancer and strategies to reduce morbidity for patients undergoing prostate biopsy.

Association of Inflammatory Bowel Disease and Prostate Cancer

Shilajit Kundu, MD, Professor of Urology at Northwestern Medicine describes the physiologic and genetic link between gut inflammation and prostate cancer risk, and potential targets that may be used in mitigating risk of inflammation induced tumorigenesis of the prostate.

Salvage Treatment for Prostate Cancer

Ashley Ross, MD, Professor of Urology at Northwestern Medicine discusses treatment plans for recurring prostate cancer also called second-line or salvage treatment.

PET Imaging in Prostate Cancer

Hatice Savas, MD, Assistant Professor of Radiology, discusses current PET radiotracers that are used in prostate cancer imaging and newly approved PSME PET tracers.

Is there still a role for docetaxel in mHSPC?

Sweeney Christopher, MBBS, Medical Oncologist at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School describes treatment selections in metastatic hormone-sensitive prostate cancer (mHSPC).

Implementation of Smoking Cessation in Urologic Oncology Practice

Richard Matulewicz, MD, MSCI, MS, Urologic Oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) and Assistant Professor at Weill Cornell Medical College, explains how cigarette smoking is associated with several genitourinary disease processes, but is most causally linked with bladder cancer.

Robotic Reconstruction of Complications in Urologic Oncology

Ziho Lee, MD, Assistant Professor of Urology at Northwestern Medicine discuss the contemporary use of robotic assistance in the treatment of complications following urologic oncologic procedures.

Prostate Cancer for Gay and Bisexual Men

Channa Amarasekera, MD, Assistant Professor of Urology at Northwestern University Feinberg School of Medicine, discusses the emerging medical and public health concern of prostate cancer in gay, bisexual, and other men who have sex with men (GBM).

Highlights in Urologic Oncology from ASCO 2022

David VanderWeele, MD, PhD, Assistant Professor of Medicine in Hematology/Oncology, reviews the clinical and translational GU oncology research presented during the 2022 ASCO annual meeting.

Computational Pathology and The Future of Diagnosis

Lee Cooper, PhD, Associate Professor & Director of Computational Pathology at Northwestern Medicine, uncover the potential of computational pathology & how it can help bring about a precision diagnosis future.

Rational Treatment of HRR-Deficient Prostate Cancer

Emmanuel S. Antonarakis, MD, Clark Endowed Professor of Medicine and Director of Genitourinary Oncology in the Department of Medicine’s Division of Hematology, Oncology, and Transplantation (HOT) of the University of Minnesota Medical School assesses the treatment options for Homologous Recombination Repair (HRR)-deficient prostate cancer.

The Role of Partial Nephrectomy in the Management of Wilms Tumor.

Edward Gong, MD, Pediatric Urologist at Ann & Robert H. Lurie Children's Hospital of Chicago describes how partial nephrectomies may be an viable surgical option for Wilms Tumor.

Optimizing Retroperitoneal Lymph Node Dissection (RPLND); Anatomic and Technical Considerations

Joel Sheinfeld, MD, Florence &Theodore Baumritter/ Enid Ancell Chair of Urologic Oncology, Vice-Chairman/ Deputy Chief of Urology at Memorial Sloan Kettering Cancer Center (MSKCC) and Program Director of the Urology Fellowship, describes the complex neurovascular relationships that are crucial to performing a successful nerve-sparing retroperitoneal lymph node dissection (RPLND), as well as surgical techniques.

Follow the Lurie Cancer Center on

Follow the Department of Urology on